In the specialty of fertility treatments Stockholm Care primarily work together with the Department of Reproductive Medicine at Karolinska University Hospital. The department offers a full range of different types of assisted reproductive technology and is specialized in complex investigations and advanced treatments of infertility in both men and women, as well as in methods for fertility preservation.
Within the Department of Reproductive Medicine you will find the Stockholm PGD center. The center was established in1996 and is a collaboration between Reproductive Medicine, (responsible for IVF, in vitro fertilization and biopsy of embryos), and Clinical genetics that establishes and perform the genetic diagnostics.
The Program for foreign patients include the following areas:
Preimplantation genetic diagnosis (PGD)
Pre-implantation genetic diagnosis (PGD) or Pre-implantation genetic testing (PGT) refers to genetic testing of early embryos, before pregnancy has started.
PGD is an alternative to traditional prenatal diagnosis for patients with inherited chromosomal aberrations or inherited monogenic disorders. The patients have to undergo an IVF treatment in order to generate embryos that can be subjected to a biopsy and tested for the specific disorder that is inherited within the family. An embryo that is diagnosed as unaffected can then be transferred back to the female uterus and a pregnancy can be initiated.
The advantage of PGD compared to conventional prenatal diagnosis is that pregnancy can be initiated with the knowledge that the expected child will not suffer from the disease. The chance for pregnancy is about 30-35% for each transfer. For more information: (link to brochure).
Fertility Preservation measures (FP)
The Department of Reproductive Medicine´s program for fertility preservation was started in the mid 90’s and has since then been at the cutting edge of development in the area.
Fertility preservation methods are indicated when medications, usually chemotherapy for treatment of cancer or for other diseases, radiation therapy or surgery, have a high risk to damage the reproductive organs. At the department of Reproductive Medicine semen (sperm), testicular tissue, ovarian tissue (ovaries), oocytes (eggs) and embryos (fertilized eggs) can be frozen and stored at the tissue bank.
Cryopreservation of sperm
Patients scheduled to undergo treatments damaging the testis or testicular surgery can provide semen samples for freezing and storage at our tissue bank.
Cryopreservation of oocytes (eggs)
Patients scheduled to undergo treatments damaging the ovary and the eggs can undergo hormonal treatment to retrieve mature eggs that can be frozen. Women with a partner may wish to fertilize the eggs and freeze embryos instead. If there is a plan for freezing of embryos (fertilized eggs), the partner has to give a semen sample at the same time.
Rules – fertility preservation methods
In general, adult women are recommended fertility preservation by methods that have developed to the clinical level. These include the freezing of eggs and embryos. The freezing of ovarian tissue is still considered experimental today. An evaluation of the woman’s chances to save fertility potential through fertility preservation methods usually include a consultation with a reproductive medicine specialist and a blood test to determine hormone concentrations.
Men are offered fertility preservation measure, freezing of sperm or testicular tissue. The man’s age depends on when he can be declared healthy. His age may not exceed 55 years in the event of later fertility treatment.